{"id":80074,"date":"2026-06-11T11:23:50","date_gmt":"2026-06-11T15:23:50","guid":{"rendered":"https:\/\/tvdelmarva.com\/wp\/british-health-agency-clears-novo-nordisk-weight-loss-pill-for-public-use\/"},"modified":"2026-06-11T11:23:50","modified_gmt":"2026-06-11T15:23:50","slug":"british-health-agency-clears-novo-nordisk-weight-loss-pill-for-public-use","status":"publish","type":"post","link":"https:\/\/tvdelmarva.com\/wp\/british-health-agency-clears-novo-nordisk-weight-loss-pill-for-public-use\/","title":{"rendered":"British Health Agency Clears Novo Nordisk Weight-Loss Pill for Public Use"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"450\" height=\"300\" src=\"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/06\/news-1781191429841.jpg?resize=450%2C300&#038;ssl=1\" alt=\"\" class=\"wp-image-80073\" srcset=\"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/06\/news-1781191429841.jpg?w=450&amp;ssl=1 450w, https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/06\/news-1781191429841.jpg?resize=300%2C200&amp;ssl=1 300w\" sizes=\"auto, (max-width: 450px) 100vw, 450px\" \/><\/figure>\n\n\n<p>Britain&#8217;s drug regulatory authority granted approval Thursday for a new oral weight-loss medication from Novo Nordisk, providing patients with an injection-free option for treating obesity while strengthening the Danish pharmaceutical company&#8217;s competitive position ahead of U.S. competitor Eli Lilly.<\/p><p>This regulatory clearance offers a more user-friendly treatment choice for over 10 million residents of England as pharmaceutical companies compete to broaden the reach of these medications, which have revolutionized the weight-loss treatment market and transformed the drug industry landscape.<\/p><p>The Medicines and Healthcare products Regulatory Agency has cleared the Wegovy pill for adult patients dealing with obesity who maintain a body mass index of 30 or higher, as well as individuals with BMI readings from 27 to 30 who also have at least one obesity-related health condition.<\/p><p>Following this regulatory clearance, Britain&#8217;s National Institute for Health and Care Excellence will conduct its own evaluation before the medication becomes accessible through the NHS healthcare system.<\/p><p>In the interim, patients may obtain the pill from private healthcare providers. Novo anticipates the medication will become accessible through private prescriptions in the coming weeks.<\/p><p>Danielle Brightman, clinical director at digital healthcare platform Numan, stated that clearing oral medication means &#8220;better access for more people battling obesity&#8221;.<\/p><p>Current NHS England data indicates that obesity impacts approximately 30% of adults in England, representing roughly 13 million to 14 million individuals.<\/p><p>The Novo pill features semaglutide, the identical active compound found in the company&#8217;s highly successful injectable medications Wegovy for weight management and Ozempic for diabetes treatment.<\/p>","protected":false},"excerpt":{"rendered":"<p>Britain&#8217;s drug regulatory authority has given the green light to a new oral weight-loss medication from Novo Nordisk on Thursday. The pill-form treatment offers patients an alternative to injections and could benefit millions struggling with obesity across England.<\/p>\n","protected":false},"author":4,"featured_media":80073,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[837],"tags":[],"class_list":["post-80074","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/06\/news-1781191429841.jpg?fit=450%2C300&ssl=1","jetpack_shortlink":"https:\/\/wp.me\/pbtNqq-kPw","jetpack-related-posts":[{"id":27102,"url":"https:\/\/tvdelmarva.com\/wp\/danish-pharma-giant-strikes-2-1b-deal-for-new-oral-weight-loss-medications\/","url_meta":{"origin":80074,"position":0},"title":"Danish Pharma Giant Strikes $2.1B Deal for New Oral Weight Loss Medications","author":"Admin","date":"February 25, 2026","format":false,"excerpt":"Novo Nordisk has entered a partnership worth up to $2.1 billion with U.S. company Vivtex to create pill versions of obesity and diabetes treatments. The collaboration aims to transform injectable medications into oral drugs using advanced delivery technology.","rel":"","context":"In &quot;Business&quot;","block_context":{"text":"Business","link":"https:\/\/tvdelmarva.com\/wp\/category\/business\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/02\/news-1772028044719.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":61879,"url":"https:\/\/tvdelmarva.com\/wp\/danish-drugmakers-weight-loss-pill-faces-intense-competition-battle\/","url_meta":{"origin":80074,"position":1},"title":"Danish Drugmaker&#8217;s Weight-Loss Pill Faces Intense Competition Battle","author":"Admin","date":"May 5, 2026","format":false,"excerpt":"Novo Nordisk is experiencing strong early sales for its new weight-loss pill, but investors are questioning whether the success can overcome a fierce pricing battle in the obesity drug market. The company faces mounting pressure as U.S. competitor Eli Lilly has launched a rival pill, setting up a head-to-head competition.","rel":"","context":"In &quot;Business&quot;","block_context":{"text":"Business","link":"https:\/\/tvdelmarva.com\/wp\/category\/business\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/05\/news-1777965890792.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":45049,"url":"https:\/\/tvdelmarva.com\/wp\/wegovy-maker-offers-new-discount-plans-to-compete-in-weight-loss-drug-market\/","url_meta":{"origin":80074,"position":2},"title":"Wegovy Maker Offers New Discount Plans to Compete in Weight Loss Drug Market","author":"Admin","date":"March 31, 2026","format":false,"excerpt":"Danish pharmaceutical company Novo Nordisk is rolling out subscription-based pricing for its weight loss medication Wegovy, offering discounts up to 29% for patients who pay out of pocket. The move comes as the company battles competitor Eli Lilly for market share in the rapidly growing obesity treatment sector.","rel":"","context":"In &quot;Health&quot;","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1774959774994.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":32529,"url":"https:\/\/tvdelmarva.com\/wp\/major-drug-companies-rush-to-develop-weight-loss-pills-as-market-shifts\/","url_meta":{"origin":80074,"position":3},"title":"Major Drug Companies Rush to Develop Weight-Loss Pills as Market Shifts","author":"Admin","date":"March 6, 2026","format":false,"excerpt":"The weight-loss medication industry is undergoing major changes as pharmaceutical companies race to create pill versions of popular injectable treatments. With oral alternatives emerging and prices dropping, Wall Street analysts are reconsidering their predictions of a $150 billion market within ten years.","rel":"","context":"In &quot;Health&quot;","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":31039,"url":"https:\/\/tvdelmarva.com\/wp\/weight-loss-pill-company-plans-comeback-after-regulatory-troubles\/","url_meta":{"origin":80074,"position":4},"title":"Weight-Loss Pill Company Plans Comeback After Regulatory Troubles","author":"Admin","date":"March 3, 2026","format":false,"excerpt":"An Arizona pharmacy that partnered with telehealth company Hims & Hers is planning to bring back its controversial weight-loss pill after pulling it due to federal regulatory concerns. The company will work with other healthcare providers this time around, though no timeline has been set.","rel":"","context":"In &quot;Health&quot;","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/03\/news-1772554787272.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":21460,"url":"https:\/\/tvdelmarva.com\/wp\/indian-pharmaceutical-company-plans-cheaper-alternative-to-popular-weight-loss-drug\/","url_meta":{"origin":80074,"position":5},"title":"Indian Pharmaceutical Company Plans Cheaper Alternative to Popular Weight Loss Drug","author":"Admin","date":"February 17, 2026","format":false,"excerpt":"Dr Reddy's Laboratories announced plans to offer a generic version of the weight loss medication Wegovy at 60% below the original price, pending regulatory approval. The Indian pharmaceutical company recently gained approval to produce a generic version of diabetes drug Ozempic and is now seeking permission for the weight loss\u2026","rel":"","context":"In &quot;Health&quot;","block_context":{"text":"Health","link":"https:\/\/tvdelmarva.com\/wp\/category\/health\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tvdelmarva.com\/wp\/wp-content\/uploads\/2026\/02\/news-1771334286607.jpg?fit=450%2C300&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]}],"jetpack_sharing_enabled":true,"jetpack_likes_enabled":true,"_links":{"self":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts\/80074","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/comments?post=80074"}],"version-history":[{"count":0,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/posts\/80074\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/media\/80073"}],"wp:attachment":[{"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/media?parent=80074"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/categories?post=80074"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tvdelmarva.com\/wp\/wp-json\/wp\/v2\/tags?post=80074"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}